Location History:
- East Lyme, CT (US) (2002 - 2004)
- San Diego, CA (US) (2006 - 2022)
Company Filing History:
4 out of 4,455 
4 out of 3,870 
3 out of 174 Years Active: 2002-2025
Title: Innovator Spotlight: Hai Wang, Pioneering Nanoparticle Therapeutics
Introduction:
Hai Wang, a distinguished inventor based in San Diego, CA, has made significant contributions to the field of biopharmaceuticals through his groundbreaking research and innovative patents. With a portfolio of 10 patents to his name, Wang's work focuses on ionizable compounds and their applications in nanoparticle compositions for advanced therapeutics.
Latest Patents:
Wang's most recent patents, "Ionizable compounds and compositions and uses thereof," underscore his expertise in developing novel compounds for biomedical applications. These inventions center around utilizing ionizable compounds to create nanoparticle formulations that effectively encapsulate active agents, such as nucleic acids, and facilitate targeted delivery to specific cells, tissues, and organs.
Career Highlights:
Having worked at esteemed pharmaceutical companies like Pfizer and Agouron Pharmaceuticals, Wang has honed his skills and expertise in drug development and delivery systems. His tenure at these industry-leading organizations has provided him with invaluable experience in translating scientific discoveries into tangible solutions for healthcare challenges.
Collaborations:
Throughout his career, Wang has collaborated with industry peers such as Michael Bruno Plewe and Junhu Zhang, renowned experts in the field of biopharmaceuticals. These collaborations have not only enriched Wang's research endeavors but have also led to the development of cutting-edge technologies with the potential to revolutionize medical treatments.
Conclusion:
In conclusion, Hai Wang stands as a trailblazing innovator in the realm of nanoparticle therapeutics, with a proven track record of transforming scientific concepts into patented inventions that push the boundaries of biopharmaceutical research. His dedication to advancing drug delivery technologies has positioned him as a visionary in the industry, with the potential to drive substantial progress in healthcare innovation.